Results
|
34681.
|
|
|
34682.
|
|
|
34683.
|
|
|
34684.
|
|
|
34685.
|
|
|
34686.
|
|
|
34687.
|
|
|
34688.
|
|
|
34689.
|
|
|
34690.
|
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. [electronic resource] by
- Kanamaru, A
- Takemoto, Y
- Kakishita, E
- Dohy, H
- Kodera, Y
- Moriyama, Y
- Shibata, A
- Kasai, M
- Katoh, S
- Saitoh, H
Producer: 19951212
In:
Bone marrow transplantation vol. 15
Availability: No items available.
|
|
34691.
|
|
|
34692.
|
|
|
34693.
|
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. [electronic resource] by
- Wolff, S N
- Fay, J
- Stevens, D
- Herzig, R H
- Pohlman, B
- Bolwell, B
- Lynch, J
- Ericson, S
- Freytes, C O
- LeMaistre, F
- Collins, R
- Pineiro, L
- Greer, J
- Stein, R
- Goodman, S A
- Dummer, S
Producer: 20000621
In:
Bone marrow transplantation vol. 25
Availability: No items available.
|
|
34694.
|
Effective and safe interferon treatment for Japanese patients with chronic myelogenous leukemia relapse after bone marrow transplantation. The Nagoya Blood and Marrow Transplantation Group. [electronic resource] by
- Sao, H
- Kato, C
- Kitaori, K
- Adachi, T
- Yano, K
- Kobayashi, M
- Kojima, H
- Tanimoto, M
- Hirabayashi, N
- Minami, S
- Yamada, H
- Morishita, G Y
- Morishima, Y
- Kodera, Y
Producer: 20001205
In:
International journal of hematology vol. 72
Availability: No items available.
|
|
34695.
|
|
|
34696.
|
|
|
34697.
|
A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. [electronic resource] by
- Pecora, A L
- Stiff, P
- LeMaistre, C F
- Bayer, R
- Bachier, C
- Goldberg, S L
- Parthasarathy, M
- Jennis, A A
- Smith, A K
- Douville, J
- Chen, B
- Armstrong, R D
- Mandalam, R K
- Preti, R
Producer: 20020307
In:
Bone marrow transplantation vol. 28
Availability: No items available.
|
|
34698.
|
|
|
34699.
|
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years. [electronic resource] by
- Kulkarni, S
- Powles, R
- Treleaven, J
- Singhal, S
- Horton, C
- Sirohi, B
- Bhagawati, N
- Tait, D
- Saso, R
- Killick, S
- Pinkerton, R
- Atra, A
- Meller, S
- Mehta, J
Producer: 20000404
In:
Bone marrow transplantation vol. 25
Availability: No items available.
|
|
34700.
|
|